US President Donald Trump announced 100% tariffs on all pharmaceutical imports into the US from October 1, unless a company is building its plant in the US. "'Is building' will be defined as 'breaking ground' and/or 'under construction,'" Trump clarified. India, which is called the ‘pharmacy of the world’ for its significant pharmaceutical exports, may be impacted by the tariffs.